Sign in

CIK 0001099800

  • Large accelerated filer

Edwards Lifesciences Corp

Sign in to watch
Ticker
EW
Exchange
NYSE
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
364316614
Phone
+1 949-250-2500
Business address
ONE EDWARDS WAY, IRVINE, CA, 92614
Former names
CVG CONTROLLED INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$10,886,105
in 9 filings, $7.6M under 10b5-1 plans

Net −$10,886,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-04-01 Ullem Scott B. CVP, Chief Financial Officer Sale 10b5-1 −868 $95.51 $83K 25,461
2024-04-01 Ullem Scott B. CVP, Chief Financial Officer Sale 10b5-1 −6,387 $94.81 $606K 19,074
2024-04-01 Ullem Scott B. CVP, Chief Financial Officer Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 −7,255 7,250
2024-03-13 BOBO DONALD E JR CVP,Strategy/Corp Development Exercise or conversion 10b5-1 +14,500 $36.75 $533K 54,002.69
2024-03-13 BOBO DONALD E JR CVP,Strategy/Corp Development Sale 10b5-1 −14,500 $91.01 $1.3M 39,502.69
2024-03-13 BOBO DONALD E JR CVP,Strategy/Corp Development Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 −14,500 12,500
2024-03-11 Lemercier Jean-Luc M CVP, EMEACLA and JAPAC Exercise or conversion 10b5-1 +14,400 $36.75 $529K 187,983.78
2024-03-11 Lemercier Jean-Luc M CVP, EMEACLA and JAPAC Sale 10b5-1 −14,400 $91.68 $1.3M 173,583.78
2024-03-11 Lemercier Jean-Luc M CVP, EMEACLA and JAPAC Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 −14,400 28,800
2024-03-07 Lippis Daniel J. CVP, JAPAC Exercise or conversion 10b5-1 +1,715 $36.75 $63K 18,928.21
2024-03-07 Lippis Daniel J. CVP, JAPAC Sale 10b5-1 −1,715 $90.98 $156K 17,213.21
2024-03-07 Lippis Daniel J. CVP, JAPAC Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 −1,715 1,714
2024-03-04 MUSSALLEM MICHAEL A Director Exercise or conversion 10b5-1 +29,350 $36.75 $1.1M 33,835.82
2024-03-04 MUSSALLEM MICHAEL A Director Sale 10b5-1 −13,310 $86.21 $1.1M 20,525.82
2024-03-04 MUSSALLEM MICHAEL A Director Sale 10b5-1 −16,040 $87.05 $1.4M 4,485.82
2024-03-04 MUSSALLEM MICHAEL A Director Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 −29,350 58,700
2024-02-29 Ullem Scott B. CVP, Chief Financial Officer Exercise or conversion 10b5-1 +7,255 $36.75 $267K 26,329
2024-02-29 Ullem Scott B. CVP, Chief Financial Officer Sale 10b5-1 −7,255 $85.59 $621K 19,074
2024-02-29 Ullem Scott B. CVP, Chief Financial Officer Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 −7,255 14,505
2024-02-23 GALLAHUE KIERAN Director Exercise or conversion +7,056 $36.86 $260K 10,757

Page 28 of 43 · 841 trades